Oral Oncology
Volume 46, Issue 3 , Pages 158-165 , March 2010

Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1

  • Yu-Chih Chen

      Affiliations

    • Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei 11217, Taiwan
    • Institute of Clinical Medicine, National Yang-Ming University, Taipei 11221, Taiwan
    • Equal to contribution.
    • ,
  • Charn-Jung Chang

      Affiliations

    • Department of Pharmacy, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan
    • Pharmaceutical Management Division, Medical Affairs Bureau, Minister of National Defense
    • Equal to contribution.
    • ,
  • Han-Shui Hsu

      Affiliations

    • Institute of Emergency and Critical Care Medicine, National Yang-Ming University, Taipei 11221, Taiwan
    • Department of Surgery, Taipei Veterans General Hospital, Taipei 11217, Taiwan
    • Equal to contribution.
    • ,
  • Yi-Wei Chen

      Affiliations

    • Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei 11217, Taiwan
    • Institute of Clinical Medicine, National Yang-Ming University, Taipei 11221, Taiwan
    • Equal to contribution.
    • ,
  • Lung-Kuo Tai

      Affiliations

    • Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei 11217, Taiwan
    • Institute of Clinical Medicine, National Yang-Ming University, Taipei 11221, Taiwan
    • ,
  • Ling-Ming Tseng

      Affiliations

    • Institute of Clinical Medicine, National Yang-Ming University, Taipei 11221, Taiwan
    • Department of Surgery, Taipei Veterans General Hospital, Taipei 11217, Taiwan
    • ,
  • Guang-Yuh Chiou

      Affiliations

    • Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei 11217, Taiwan
    • Institute of Clinical Medicine, National Yang-Ming University, Taipei 11221, Taiwan
    • ,
  • Shih-Ching Chang

      Affiliations

    • Institute of Clinical Medicine, National Yang-Ming University, Taipei 11221, Taiwan
    • Department of Surgery, Taipei Veterans General Hospital, Taipei 11217, Taiwan
    • ,
  • Shou-Yen Kao

      Affiliations

    • Division of Oral and Maxillofacial Surgery, Department of Stomatology, Taipei Veterans General Hospital, Taipei 11217, Taiwan
    • Department of Dentistry, National Yang-Ming University, Taipei 11221, Taiwan
    • ,
  • Shih-Hwa Chiou

      Affiliations

    • Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei 11217, Taiwan
    • Institute of Clinical Medicine, National Yang-Ming University, Taipei 11221, Taiwan
    • ,
  • Wen-Liang Lo

      Affiliations

    • Division of Oral and Maxillofacial Surgery, Department of Stomatology, Taipei Veterans General Hospital, Taipei 11217, Taiwan
    • Department of Dentistry, National Yang-Ming University, Taipei 11221, Taiwan
    • Corresponding Author InformationCorresponding author. Address: Division of Oral and Maxillofacial Surgery, Department of Stomatology, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Road, Taipei 11217, Taiwan. Tel.: +886 2 2875 7572; fax: +886 2 2874 2375.

Received 19 October 2009 ,Revised 17 November 2009 ,Accepted 17 November 2009.

References 

  1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–2150
  2. Khawaja MR, Mazahir S, Majeed A, Malik F, Merchant KA, Maqsood M, et al. Chewing of betel, areca and tobacco: perceptions and knowledge regarding their role in head and neck cancers in an urban squatter settlement in Pakistan. Asian Pac J Cancer Prev. 2006;7:95–100
  3. Lo WL, Kao SY, Chi LY, Wong YK, Chang RC. Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. J Oral Maxillofac Surg. 2003;61:751–758
  4. Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature. 2003;425:962–967
  5. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature. 2003;423:302–305
  6. Sangiorgi E, Capecchi MR. Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet. 2008;40:915–920
  7. Haupt Y, Alexander WS, Barri G, Klinken SP, Adams JM. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell. 1991;65:753–763
  8. Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, van Lohuizen M. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev. 1999;13:2678–2690
  9. Qin ZK, Yang JA, Ye YL, Zhang X, Xu LH, Zhou FJ, et al. Expression of Bmi-1 is a prognostic marker in bladder cancer. BMC Cancer. 2009;9:61
  10. Cooper CS, Foster CS. Concepts of epigenetics in prostate cancer development. Br J Cancer. 2009;100:240–245
  11. Tirabosco R, De Maglio G, Skrap M, Falconieri G, Pizzolitto S. Expression of the Polycomb-group protein BMI1 and correlation with p16 in astrocytomas an immunohistochemical study on 80 cases. Pathol Res Pract. 2008;204:625–631
  12. Hayry V, Tynninen O, Haapasalo HK, Wolfer J, Paulus W, Hasselblatt M, et al. Stem cell protein BMI-1 is an independent marker for poor prognosis in oligodendroglial tumours. Neuropathol Appl Neurobiol. 2008;34:555–563
  13. Arnes JB, Collett K, Akslen LA. Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1. Histopathology. 2008;52:370–380
  14. Vrzalikova K, Skarda J, Ehrmann J, Murray PG, Fridman E, Kopolovic J, et al. Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study. J Cancer Res Clin Oncol. 2008;134:1037–1042
  15. Sparmann A, van Lohuizen M. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer. 2006;6:846–856
  16. Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med. 2006;355:1253–1261
  17. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA. 2007;104:973–978
  18. Okamoto A, Chikamatsu K, Sakakura K, Hatsushika K, Takahashi G, Masuyama K. Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Oral Oncol. 2009;45:633–639
  19. Chen YC, Chen YW, Hsu HS, Tseng LM, Huang PI, Lu KH, et al Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun. 2009;385:307–313
  20. Zhang P, Zhang Y, Mao L, Zhang Z, Chen W. Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes. Cancer Lett. 2009;277:227–234
  21. Chiou SH, Kao CL, Chen YW, Chien CS, Hung SC, Lo JF, et al. Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor. PLoS ONE. 2008;3:e2090
  22. Boiani M, Scholer HR. Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol. 2005;6:872–884
  23. Iwama A, Oguro H, Negishi M, Kato Y, Morita Y, Tsukui H, et al. Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity. 2004;21:843–851
  24. Jiang L, Li J, Song L. Bmi-1, stem cells and cancer. Acta Biochim Biophys Sin (Shanghai). 2009;41:527–534
  25. Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G, et al. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 2008;68:9125–9130
  26. Yang J, Chai L, Liu F, Fink LM, Lin P, Silberstein LE, et al. Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells. Proc Natl Acad Sci USA. 2007;104:10494–10499
  27. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–996
  28. Lee CJ, Dosch J, Simeone DM. Pancreatic cancer stem cells. J Clin Oncol. 2008;26:2806–2812
  29. Vormittag L, Thurnher D, Geleff S, Pammer J, Heiduschka G, Brunner M, et al. Co-expression of Bmi-1 and podoplanin predicts overall survival in patients with squamous cell carcinoma of the head and neck treated with radio(chemo)therapy. Int J Radiat Oncol Biol Phys. 2009;73:913–918

PII: S1368-8375(09)00976-2

doi: 10.1016/j.oraloncology.2009.11.007

Oral Oncology
Volume 46, Issue 3 , Pages 158-165 , March 2010

Article Tools

* Image Usage & Resolution